0

Orthobiologics Market by Product and Geography - Forecast and Analysis 2021-2025

  • Published: Jul 2021
  • Pages: 120
  • SKU: IRTNTR70811
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

“The Orthobiologics Market  study is a comprehensive report with in-depth qualitative and quantitative research evaluating the current scenario and analyzing the growth of USD 2.02 billion and CAGR of 7.01% by segment Product and Geography during the forecast period 2022 to 2027” 

Furthermore, this report extensively covers market segmentations by Product (Bone graft substitutes, Viscosupplementation, and Stem cells) and Geography (North America, Europe, Asia, and ROW). The market report also offers information on several market vendors, including Advanced Medical Solutions Group Plc, Akcome Medical Holdings Co. Ltd. , Anika Therapeutics Inc., Arthrex Inc., Bioventus LLC, Globus Medical Inc., Johnson and Johnson Inc., Medtronic Plc, Nuvasive Inc., and Stryker Corp.

Orthobiologics Market Size

Download Report Sample to Unlock the Smart Room Heater Market Size for the Forecast Period and Other Important Statistics 

Parent Market Analysis

Technavio categorizes the Orthobiologics Market as a part of the Health Care industry within the Biotechnology industry. Our Technavio research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the forecast year.

Orthobiologics Market: Key Drivers, Trends, and Challenges

Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the orthobiologics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge. 

Key Orthobiologics Market Driver

One of the key factors driving growth in the orthobiologics market is the increasing prevalence of orthopedic disorders coupled with an ageing population. There has been a significant increase in the number of orthopedic disorders across the world over the last decade. Limited physical activity and eating habits can negatively influence the body's homeostasis. This complication intensifies with aging, making most people aged 60 years and above susceptible to orthopedic diseases such as arthritis. Osteoarthritis in people of this age group can affect the joints and put stress on the knees, hips, and lower spine. Sophisticated treatment options and improved standards for healthcare have increased life expectancy, resulting in a further rise in the population of this age group. Arthritis, trauma, back pain, and osteoporosis are the most common joint problems worldwide. Globally, the geriatric population has been increasing rapidly. As per The World Bank Group and the NIH, the proportion of the global geriatric population is expected to grow from 8.48% in 2016 to approximately 17% by 2050. According to the CDC, in 2019, about 65.6% of adults aged 65 years and above visited dental surgeons. Such an increase in the prevalence of orthopedic disorders requires orthobiologics for the fixation or binding of joint disorders. Thus, the increasing number of orthopedic disorders will increase the demand for orthobiologics and thus drive market growth. 

Key Orthobiologics Market Challenge

 

The high costs and inadequate reimbursements for orthobiologics products and procedures will be a major challenge for the orthobiologics market during the forecast period. The high pricing of orthobiologics products and procedures is one of the major challenges for the growth of the global orthobiologics market. The expansion of the geriatric population base and a subsequent increase in the number of orthopedic disorders have led to an increased need for orthobiologics. Advanced orthobiologics products are readily available in the market, especially in developed countries such as the US. However, the high cost of these products hinders their adoption in developing and underdeveloped economies. Inadequate reimbursements available for orthobiologics are also a major factor for the low use of these products and devices. For instance, the reimbursement for orthobiologics is complex in the US due to stringent FDA regulations and the multi-payor system. The high costs of orthobiologics products, such as novel bone grafts, also create difficulties in obtaining reimbursement, thereby resulting in poor adoption rates in economically weak nations. Therefore, for manufacturers to be successful, the development of a comprehensive plan for reimbursement before obtaining FDA approval becomes essential. The impact of these factors, however, is expected to reduce in the near future, as many manufacturers are planning to develop affordable orthobiologics products. 

Orthobiologics Market Value Chain Analysis

Our In-house experts produce extensive information on the value chain, and parent market of orthobiologics market which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-end understanding of product insight and profit and also optimization and evaluation of business strategies The players across the value chain includes selective data and analysis from entire research findings as per the scope of the report.

Who are the Major Orthobiologics Market Vendors?

  • Akcome Medical Holdings Co. Ltd.  - The company offers orthobiologics such as RegenOss, ENGIpore, SINTLife, and MaioRegen.

    Unified: Under this segment, the company offers production and sale of bone and joint implants, spinal implants, trauma implants and a complete set of surgical instruments.

The report  on Orthobiologics Market analyzes the market’s competitive landscape and offers information on several market vendors, including: 

 

  • Advanced Medical Solutions Group Plc
  • Akcome Medical Holdings Co. Ltd. 
  • Anika Therapeutics Inc.
  • Arthrex Inc.
  • Bioventus LLC
  • Globus Medical Inc.
  • Johnson and Johnson Inc.
  • Medtronic Plc
  • Nuvasive Inc.
  • Stryker Corp.

 

This statistical study of the orthobiologics market encompasses successful business strategies deployed by the key vendors. The orthobiologics market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market. The vendor profiles are designed to help clients improve their market position, and information on production and sustainability along with this the report provides a detailed analysis of several leading Companies.

Which are the Key Regions for Orthobiologics Market?

Orthobiologics Market Share by Geography

For more insights on the market share of various regions Request PDF Sample now!

41% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for orthobiologics in North America. Market growth in this region will be faster than the growth of the market in the European regions.

In 2020, North America dominated the market and was likely to retain its position during the forecast period due to the presence of a well-established healthcare system that provides high-quality orthobiologics. High obesity rates and a rise in the incidence of arthritis have surged the demand for minimally invasive procedures such as bone grafting. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 in 2020 affected all countries in North America, especially the US. It had a mixed impact on the orthobiologics market in the region in 2020. As of July 17, 2021, more than 34.96 million cases of COVID-19 were reported in the US. A rise in the number of cases in the first quarter of 2020 led to complete lockdowns in several countries, including Canada and Mexico. Thus, various non-urgent treatments and clinical visits were partially or completely closed as per the COVID-19 guidelines. However, by 2021, restrictions in various countries were somewhat relaxed, which included resuming business activities and offering essential services, including treatment of orthopedic conditions using orthobiologics. The relaxation of such restrictions will encourage people to go for health checkups and treatments, which in turn, will drive the growth of the orthobiologics market in North America during the forecast period.

What are the Revenue-generating Product Segments in the Orthobiologics Market?

Orthobiologics Market Share

To gain further insights on the market contribution of various segments Request a PDF Sample

The orthobiologics market share growth by the bone graft substitutes segment will be significant during the forecast period. Bone graft substitutes are synthetic, natural, and composite materials, which are used to treat bone defects and promote bone healing. They include autografts, allografts, bone morphogenetic proteins (BMP), synthetic bone grafts, demineralized bone matrix (DBM), platelet-rich plasma (PRP), an autologous conditioned serum. The market for bone graft substitutes is driven by the rise in the prevalence of osteoarthritis due to the rise in the geriatric population, osteoporosis, and obesity.

This report provides an accurate prediction of the contribution of all the segments to the growth of the orthobiologics market size and actionable market insights on post-COVID-19 impact on each segment.

 

Orthobiologics Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 7.01%

Market growth 2021-2025

$ 2.02 billion

Market structure

Fragmented

YoY growth (%)

6.60

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 41%

Key consumer countries

US, UK, Germany, Canada, and China

Competitive landscape

Leading companies, Competitive Strategies, Consumer engagement scope

Key companies profiled

Advanced Medical Solutions Group Plc, Akcome Medical Holdings Co. Ltd. , Anika Therapeutics Inc., Arthrex Inc., Bioventus LLC, Globus Medical Inc., Johnson and Johnson Inc., Medtronic Plc, Nuvasive Inc., and Stryker Corp.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Orthobiologics Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive orthobiologics market growth during the next five years
  • Precise estimation of the orthobiologics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the orthobiologics industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of orthobiologics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Executive Summary

    Market Landscape

    • Market ecosystem
    • Market characteristics
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Product

    • Market segments
    • Comparison by Product
    • Bone graft substitutes - Market size and forecast 2020-2025
    • Viscosupplementation - Market size and forecast 2020-2025
    • Stem cells - Market size and forecast 2020-2025
    • Market opportunity by Product

    Geographic Landscape

    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Market trends

    Vendor Landscape

    • Overview
    • Vendor landscape
    • Landscape disruption

    Vendor Analysis

    • Vendors covered
    • Market positioning of vendors
    • Advanced Medical Solutions Group Plc
    • Akcome Medical Holdings Co. Ltd. 
    • Anika Therapeutics Inc.
    • Arthrex Inc.
    • Bioventus LLC
    • Globus Medical Inc.
    • Johnson and Johnson Inc.
    • Medtronic Plc
    • Nuvasive Inc.
    • Stryker Corp.

    Appendix

    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

    Research Framework

    Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

    TechnavioINFORMATION SOURCES

    Primary sources

    • Manufacturers and suppliers
    • Channel partners
    • Industry experts
    • Strategic decision makers

    Secondary sources

    • Industry journals and periodicals
    • Government data
    • Financial reports of key industry players
    • Historical data
    • Press releases
    Technavio

    TechnavioDATA ANALYSIS

    Data Synthesis

    • Collation of data
    • Estimation of key figures
    • Analysis of derived insights

    Data Validation

    • Triangulation with data models
    • Reference against proprietary databases
    • Corroboration with industry experts
    Technavio

    TechnavioREPORT WRITING

    Qualitative

    • Market drivers
    • Market challenges
    • Market trends
    • Five forces analysis

    Quantitative

    • Market size and forecast
    • Market segmentation
    • Geographical insights
    • Competitive landscape
    Interested in this report?
    Get your sample now!
    Orthobiologics market growth will increase by $2023.62 million during 2020-2025.
    The orthobiologics market is expected to grow at a CAGR of 7.01% during 2020-2025.
    Technavio has segmented the orthobiologics market by product (Bone graft substitutes, Viscosupplementation, and Stem cells) and geographic (North America, Europe, Asia, and ROW).
    Advanced Medical Solutions Group Plc, Akcome Medical Holdings Co. Ltd.?á, Anika Therapeutics Inc., Arthrex Inc., Bioventus LLC, Globus Medical Inc., Johnson and Johnson Inc., Medtronic Plc, Nuvasive Inc., Stryker Corp. are a few of the key vendors in the orthobiologics market.
    North America will register the highest growth rate of 40.82% among the other regions. Therefore, the orthobiologics market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
    The key factors driving the orthobiologics market growth are:
    • Increasing prevalence of orthopedic disorders coupled with an aging population
    The orthobiologics market vendors should focus on grabbing business opportunities from the bone graft substitutes segment as it accounted for the largest market share in the base year.
    • What are the key global market and the regional market share?
    • What are the revenue-generating key market segments?
    • What are the key factors driving and challenging this market’s growth?
    • Who are the key market vendors and their growth strategies?
    • What are the latest trends influencing the growth of this market?
    • What are the variables influencing the market growth in the primary regions?
    • What are the factors influencing the growth of the parent market?
    • Off-the-shelf research reports
    • Reports can be tailored to meet the customer's needs
    • Trusted by more than 100 fortune 500 organizations
    • Information about the market's key drivers, trends, and challenges
    • Parent market analysis
    • Every week, 50,000 people visit our subscription platform
    • Detailed vendors report with competitive landscape
    • Covid-19 impact and recovery analysis
    • Data on revenue-generating market segments
    • Details on the market shares of various regions
    • Five-force market analysis

    Certified ISO 9001 : 2015

    We are ISO recognized

    We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

    We are GDPR and CCPA compliant

    We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

    Safe and Secure SSL Encrypted
    Technavio

    info
    close
    • Single:

      One user only.
      Quick & easy download option

    • Enterprise:

      Unlimited user access (Within your organization)
      Complimentary Customization Included

    2500 USD

    Technavio Get the report (PDF) sent to your email within minutes.

    Subscribe & Save

    Get lifetime access to our
    Technavio Insights

    Customized Report as per your Business Needs

    • Our analysts will work directly with you and understand your needs
    • Get data on specified regions or segments, competitor and Vendors
    • Data will be formatted and presented as per your requirements
    • We offer $1000 worth of FREE customization at the time of purchase

    Let us help you make report more suited to your requirements.

    • Get a competitive breakdown as per your niche industry
    • Customize the data with various metrics that meet your business prerequisite
    • Understand Revenue Sources, Customers and many more
    • Details on Market Share
    • These customizations are done in a short amount of time by our analysts and industry experts
    Technavio
    Enquire Before Buying
    17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>